Jw. Ellingboe et al., METABOLITES OF THE ANGIOTENSIN-II ANTAGONIST TASOSARTAN - THE IMPORTANCE OF A 2ND ACIDIC GROUP, Journal of medicinal chemistry, 41(22), 1998, pp. 4251-4260
Described in this paper is the synthesis and pharmacological activity
of five metabolites of the angiotensin II antagonist tasosartan (1). O
f particular interest is the effect of the additional acidic group of
the enol metabolite (8) on activity. As suggested by the structural-ac
tivity relationship of other angiotensin II antagonist series, a secon
d acidic group can improve receptor binding activity but decrease in v
ivo activity after oral dosing. The metabolic introduction of a second
acidic group in tasosartan bypasses this problem and contributes to t
he excellent profile of the compound. A molecular modeling study provi
des a rationale for the role of the enol group of 8 in AT(1) receptor
binding.